This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Accession codes
References
Speck NA, Stacy T, Wang Q, North T, Gu TL, Miller J et al. Core-binding factor: a central player in hematopoiesis and leukemia. Cancer Res 1999; 59: 1789s–1793s.
Le Beau MM, Larson RA, Bitter MA, Vardiman JW, Golomb HM, Rowley JD . Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association. N Engl J Med 1983; 309: 630–636.
Liu P, Tarle SA, Hajra A, Claxton DF, Marlton P, Freedman M et al. Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. Science 1993; 261: 1041–1044.
Castilla LH, Wijmenga C, Wang Q, Stacy T, Speck NA, Eckhaus M et al. Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11. Cell 1996; 87: 687–696.
Sasaki K, Yagi H, Bronson RT, Tominaga K, Matsunashi T, Deguchi K et al. Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core binding factor beta. Proc Natl Acad Sci USA 1996; 93: 12359–12363.
Kummalue T, Lou J, Friedman AD . Multimerization via its myosin domain facilitates nuclear localization and inhibition of core binding factor (CBF) activities by the CBFbeta-smooth muscle myosin heavy chain myeloid leukemia oncoprotein. Mol Cell Biol 2002; 22: 8278–8291.
Durst KL, Lutterbach B, Kummalue T, Friedman AD, Hiebert SW . The inv(16) fusion protein associates with corepressors via a smooth muscle myosin heavy-chain domain. Mol Cell Biol 2003; 23: 607–619.
Sohn RL, Vikstrom KL, Strauss M, Cohen C, Szent-Gyorgyi AG, Leinwand LA . A 29 residue region of the sarcomeric myosin rod is necessary for filament formation. J Mol Biol 1997; 266: 317–330.
D'Costa J, Chaudhuri S, Civin CI, Friedman AD . CBFbeta-SMMHC slows proliferation of primary murine and human myeloid progenitors. Leukemia 2005; 19: 921–929.
Kuo YH, Landrette SF, Heilman SA, Perrat PN, Garrett L, Liu PP et al. Cbf beta-SMMHC induces distinct abnormal myeloid progenitors able to develop acute myeloid leukemia. Cancer Cell 2006; 9: 57–68.
Kuo YH, Gerstein RM, Castilla LH . Cbfb-SMMHC impairs differentiation of common lymphoid progenitors and reveals an essential role for RUNX in early B-cell development. Blood 2008; 111: 1543–1551.
Zhao L, Cannons JL, Anderson S, Kirby M, Xu L, Castilla LH et al. CBFB-MYH11 hinders early T-cell development and induces massive cell death in the thymus. Blood 2007; 109: 3432–3440.
Hong S, Skaist AM, Wheelan SJ, Friedman AD . AP-1 protein induction during monopoiesis favors C/EBP: AP-1 heterodimers over C/EBP homodimerization and stimulates FosB transcription. J Leukoc Biol 2011; 90: 643–651.
Laslo P, Spooner CJ, Warmflash A, Lancki DW, Lee HJ, Sciammas R et al. Multilineage transcriptional priming and determination of alternate hematopoietic cell fates. Cell 2006; 126: 755–766.
Qi J, Singh S, Hua WK, Cai Q, Chao SW, Li L et al. HDAC8 inhibition specifically targets Inv(16) acute myeloid leukemia stem cells by restoring p53 acetylation. Cell Stem Cell 2015; 17: 597–610.
Acknowledgements
We thank Dr John Roth (UC-Davis) for thoughtful discussions and Dr Yufeng Li for statistical help. We sincerely apologize to colleagues whose work we were not able to cite due to space limitations. This work was supported by the NIH consortium grant to SWH (2RO1CA087549-06), by NIH RO1CA096798 and R01CA144248 (to CAK), RO1HL089176 (to ADF) and P30CA013148 (to RAO and DC).
Author contributions
H-GK, CSS, HJN, JL, SP-G, CVC, RK and LG designed and performed the experiments; RAO and DC provided biostatistical analysis; VR analyzed histology results; SWH, ADF and CAK designed experiments; H-GK and CAK wrote the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Leukemia website
Supplementary information
Rights and permissions
About this article
Cite this article
Kim, HG., LeGrand, J., Swindle, C. et al. The assembly competence domain is essential for inv(16)-associated acute myeloid leukemia. Leukemia 31, 2267–2271 (2017). https://doi.org/10.1038/leu.2017.236
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2017.236